The 4th China-Israel Investment Summit will be held at the Zhuhai International Convention and Exhibition Center from Ju...
China based biotechnology startup I-Mab Biopharma has raised $220 million in a Series C round led by Hony Capital and jo...
Yourui Pharmaceutical Technology is a leading specialty pharmaceutical company in China, headquarters in Shanghai. It ha...
Agilent Technologies Inc. has opened a new logistics hub in Shanghai, designed to enable faster delivery of parts, suppl...
Amyris, Inc., a leader in the development and production of sustainable, fermentation-derived ingredients in the markets...
Nuance Biotech, a China-based specialty pharmaceutical company, has announced Series B fundraising of US$20 million with...
Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and delivery of high quality, cost-...
OUE Lippo Healthcare Limited (OUELH) has announced that its joint venture company with leading Chinese state-owned congl...
Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs Tot Biopharm recently a...
Alibaba Group Holding Ltd. is selling its medical assets for HK$10.6 billion ($1.4 billion) to a Hong Kong-listed unit t...
Alpha Biopharma Inc has announced the first $37 million closing of its $65 million Series A financing led by Q...
Pacira Pharmaceuticals, Inc. and Nuance Biotech Co. Ltd have entered into an agreement with Nuance, a China based specia...
The research team of Hong Kong Baptist University (HKBU) has invented a medical device with a specific nanotechnology la...
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions fo...
Bristol Myers Squibb recently announced that the China National Drug Administration (CNDA) has approved ...
